[Market Review] Meta’s Nuclear Bet and the Small-Cap Awakening: KOSPI Marks 7th Straight Gain
On Monday, January 12, 2026, the South Korean stock market continued its historic start to the year. The KOSPI has now risen for seven consecutive trading days, bolstered by a massive nuclear energy deal from Meta Platforms and a long-awaited rebound in small-to-mid-cap stocks. Despite political friction in the U.S. and a volatile FX market, domestic sentiment remains resilient as liquidity begins to circulate beyond the tech giants.
1. Meta’s Nuclear Catalyst: The "Prometheus" Power Surge
Over the weekend, Meta Platforms announced a series of landmark nuclear power contracts with companies like Vistra, Oklo, and TerraPower to secure 6.6 GW of electricity for its AI data centers.
- Nuclear Sector Rally: This "Big Tech endorsement" sent Korean nuclear energy stocks soaring today. Investors are betting on a global nuclear revival as AI’s thirst for 24/7 carbon-free power reaches a fever pitch.
- Domestic Momentum: The news provided a secondary boost to established players like Doosan Enerbility (034020), which continues to benefit from both domestic SMR policy and global export demand.
2. Small-Caps Wake Up: Broadening the Market
After weeks of extreme concentration in the "Semiconductor Brothers," the market finally showed signs of broadening.
- Small-Cap Rebound: For the second consecutive day, gainers outnumbered decliners. Small-cap stocks, which had been in "oversold" territory (ADR), saw significant buying interest fueled by a recent spike in retail customer deposits.
- Key Sectors: Strong gains were seen in Space & Aerospace, PCB, and Chemical sectors, while Secondary Battery stocks rebounded on reports of a government-industry meeting regarding contract cancellations.
3. The "Powell vs. Trump" Friction & FX Volatility
The rally faced a midday hurdle as news broke regarding a Department of Justice investigation into Fed Chair Jerome Powell over alleged perjury concerning the $2.5 billion renovation of the Fed’s headquarters.
- Fed Independence Concerns: Rumors of a "criminal referral" by Trump allies sparked fears of political interference in monetary policy, causing U.S. futures to dip and prompting late-session selling in Seoul.
- FX Pressure: The USD/KRW exchange rate climbed back toward the 1,450~1,460 range, marking an 8-day upward trend. This persistent currency weakness led foreign investors to remain net sellers in the Electrical/Electronic and Transport Equipment sectors for the third straight day.
4. Institutional & Foreign Flow: Tactical Shifts
- Foreigners: Continued to offload large-cap tech while rotating into Construction, Chemicals, and Utilities. On the KOSDAQ, they focused on Electrical/Electronic and Transport Equipment.
- Institutions: Acted as a stabilizer, buying Electrical/Electronics, Machinery, and Brokerage stocks.
- Biopharma Sell-off: With the J.P. Morgan Healthcare Conference officially underway, a "sell the news" reaction hit major biotech names like Samsung Biologics (207940) and Alteogen (196170).
** Institutional Conviction: High-Relative-Strength Tickers**
As the market enters a period of high-frequency macro variables (U.S. CPI, Supreme Court rulings on tariffs), institutions are accumulating these high-conviction plays:
- Doosan Enerbility (034020): The primary domestic beneficiary of the "Meta-led" nuclear energy super-cycle.
- Hyundai Engineering & Construction (000720): Attracting institutional interest as a value play amid the infrastructure and nuclear plant construction boom.
- Mirae Asset Securities (006800): Benefiting from the "Value-Up" momentum and the structural increase in market trading volume.
- Korea Aerospace Industries (047810): Gaining strength as the Aerospace sector breaks out of its long-term consolidation.
Investor Strategy: The KOSPI’s 7-day winning streak is a testament to the "Mini-QE" effect of Trump’s housing and credit policies. While the rising exchange rate and the "Powell Investigation" create short-term noise, the trend of sector rotation is healthy. Focus on "Oversold Leaders" that have strong earnings outlooks but were recently hit by tactical profit-taking.
